Asia Pacific Arterial Blood Gas Kits Market
Published On: Apr 2025
Published On: Apr 2025
According to Business Market Insights’ research, the Asia Pacific arterial blood gas kits market was valued at US$ 1,51,398.54 thousand in 2023 and is expected to reach US$ 2,92,048.26 thousand by 2031, recording a CAGR of 8.6% from 2023 to 2031. Rising number of admissions to emergency units in hospitals and development of safe & automated kits and integration of electronic medical records are among the critical factors attributed to drive the Asia Pacific arterial blood gas kits market growth.
Hospital emergency rooms (ER) offer vital medical care for patients affected by severe chronic conditions who need immediate attention and medical intervention. The number of hospital ER admissions is growing with the rising prevalence of diabetes, cancer, heart disease, and other chronic conditions. The primary objective of emergency medical services is to provide immediate treatments for medical, surgical, and obstetric problems. According to the World Health Organization (WHO), ~150 million patients visit hospital ERs across the world annually. As emergency departments face mounting pressure to deliver rapid and accurate assessments of critically ill patients, providing timely diagnostic information on blood gas values, electrolyte levels, and acid-base balance becomes paramount. Arterial blood gas kits provide on-the-spot diagnostic data for evaluating and managing patients affected by respiratory distress or other critical conditions. The ability of these analyzers to provide real-time insights into a patient's oxygenation status and acid–base equilibrium is crucial for guiding resuscitative measures and optimizing clinical outcomes in emergency settings. Thus, the demand for technologically advanced arterial blood gas kits tailored to urgent and critical care settings is on the rise in hospital ERs, with the growing focus on enhancing emergency care services to be able to meet the needs of a rising patient population.
On the contrary, the high cost of kits and complications associated with arterial blood sampling aids hamper the growth of Asia Pacific arterial blood gas kits market.
Based on syringe type, the Asia Pacific arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held 56.9% market share in 2023, amassing US$ 86,099.16 thousand. It is projected to garner US$ 1,68,773.32 thousand by 2031 to register 8.8% CAGR during 2023–2031.
In terms of type, the Asia Pacific arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held 63.4% share of Asia Pacific arterial blood gas kits market in 2023, amassing US$ 95,959.80 thousand. It is anticipated to garner US$ 1,89,265.13 thousand by 2031 to expand at 8.9% CAGR during 2023–2031.
By usage, the Asia Pacific arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held 74.2% share of Asia Pacific arterial blood gas kits market in 2023, amassing US$ 1,12,392.89 thousand. It is projected to garner US$ 2,20,638.85 thousand by 2031 to expand at 8.8% CAGR from 2023 to 2031.
Based on application, the Asia Pacific arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held 73.4% share of Asia Pacific arterial blood gas kits market in 2023, amassing US$ 1,11,134.26 thousand. It is predicted to garner US$ 2,21,434.03 thousand by 2031 to expand at 9.0% CAGR between 2023 and 2031. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.
In terms of needle gauge, the Asia Pacific arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held 48.4% share of Asia Pacific arterial blood gas kits market in 2023, amassing US$ 73,248.93 thousand. It is estimated to garner US$ 1,45,436.18 thousand by 2031 to expand at 9.0% CAGR during 2023–2031.
Based on syringe volume, the Asia Pacific arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held 47.3% share of Asia Pacific arterial blood gas kits market in 2023, amassing US$ 71,633.35 thousand. It is projected to garner US$ 1,44,098.15 thousand by 2031 to expand at 9.1% CAGR from 2023 to 2031.
By end user, the Asia Pacific arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment held 54.5% share of Asia Pacific arterial blood gas kits market in 2023, amassing US$ 82,513.41 thousand. It is projected to garner US$ 1,64,084.34 thousand by 2031 to expand at 9.0% CAGR from 2023 to 2031.
Based on country, the Asia Pacific arterial blood gas kits market is segmented into China, Japan, India, Australia, South Korea, Kazakhstan, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.3% share of Asia Pacific arterial blood gas kits market in 2023. It was assessed at US$ 44,284.07 thousand in 2023 and is likely to hit US$ 87,290.28 thousand by 2031, registering a CAGR of 8.9% during 2023 to 2031.
Key players operating in the Asia Pacific arterial blood gas kits market are Radiometer Medical ApS, Vyaire Medical Inc, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), SARSTEDT AG & Co KG, Lepu Medical Technology Beijing Co Ltd, and Levram Lifesciences Pvt. Ltd., among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
